BIOREM Inc.
BIRMF
$1.90
$0.010.53%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 19.86% | 106.80% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 19.86% | 106.80% | |||
| Cost of Revenue | 18.07% | 97.13% | |||
| Gross Profit | 24.72% | 138.33% | |||
| SG&A Expenses | 3.50% | 49.73% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.87% | 86.48% | |||
| Operating Income | 51.52% | 1,401.96% | |||
| Income Before Tax | 56.12% | 1,980.68% | |||
| Income Tax Expenses | 56.11% | 1,987.10% | |||
| Earnings from Continuing Operations | 56.12% | 1,978.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 56.12% | 1,978.38% | |||
| EBIT | 51.52% | 1,401.96% | |||
| EBITDA | 48.74% | 483.33% | |||
| EPS Basic | 56.25% | 2,300.00% | |||
| Normalized Basic EPS | 55.94% | 2,283.33% | |||
| EPS Diluted | 55.71% | 1,964.29% | |||
| Normalized Diluted EPS | 56.10% | 1,950.00% | |||
| Average Basic Shares Outstanding | -0.15% | -13.74% | |||
| Average Diluted Shares Outstanding | 0.13% | 0.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||